Pharmacokinetics of verinurad and allopurinol in combination with cyclosporine and rifampicin in healthy volunteers

Trial Identifier:	D5495C00013
Sponsor:	AstraZeneca
Collaborator:	Parexel International
NCTID::	NCT04532918
Start Date:	September 2020
Primary Completion Date:	November 2020
Study Completion Date:	November 2020
Condition:	Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.